Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.
Elderly
Frailty
Heart failure
Heat failure with preserved ejection fraction
Physical function
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
10
02
2022
received:
04
09
2021
accepted:
02
03
2022
pubmed:
1
4
2022
medline:
6
5
2022
entrez:
31
3
2022
Statut:
ppublish
Résumé
The aim of this study was to elucidate the clinical characteristics, including frailty status, of patients with heart failure with preserved ejection fraction (HFpEF) in comparison with those in patients with heart failure with reduced ejection fraction (HFrEF) in a super-aged region of Japan. Of the 1061 Japanese patients enrolled in the Kochi YOSACOI study, a multicentre registry, we divided 645 patients (median age of 81 years [interquartile range, 72-87 years]; women, 49.1%) into two groups, HFpEF patients (61.2%) and HFrEF patients (38.8%). Physical frailty was diagnosed on the basis of the Japanese version of Cardiovascular Health (J-CHS) Study criteria. Patients for whom left ventricular ejection fraction data were not available (n = 19), patients with heart failure with mildly reduced ejection fraction (n = 172), and patients who were not assessed by the J-CHS criteria (n = 225) were excluded. The median ages of the HFpEF and HFrEF patients were 84 and 76 years, respectively. The proportion of patients with HFpEF gradually increased with advance of age. The proportion of patients with three or more comorbidities was larger in HFpEF patients than in HFrEF patients (77.9% vs. 65.6%, P = 0.003). Handgrip strength was significantly lower in HFpEF patients than in HFrEF patients for both men (P < 0.001) and women (P = 0.041). Comfortable 5 m walking speed was significantly slower in HFpEF patients than in HFrEF patients (P < 0.001). The proportions of patients with physical frailty were 55.2% in HFpEF patients and 46.8% in HFrEF patients, and the proportion was significantly higher in HFpEF patients (P = 0.043). In multivariate analysis, physical frailty was associated with advanced age [odds ratio (OR), 1.030; 95% confidence interval (CI), 1.010-1.050; P = 0.023] and low albumin level (OR, 0.334; 95% CI, 0.192-0.582; P < 0.001) in HFpEF patients, and physical frailty was associated with women (OR, 2.150; 95% CI, 1.030-4.500; P = 0.042) and anaemia (OR, 2.840; 95% CI, 1.300-6.230; P = 0.003) in HFrEF patients. In a super-aged population of HF patients in Japan, HFpEF patients are more likely to be frail/have a high frailty status compared with HFrEF patients. The results suggested that physical frailty is associated with extracardiac factors in both HFpEF patients and HFrEF patients.
Identifiants
pubmed: 35355441
doi: 10.1002/ehf2.13885
pmc: PMC9065850
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1853-1863Informations de copyright
© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Eur J Prev Cardiol. 2021 Aug 9;28(9):1022-1029
pubmed: 33624112
Eur J Heart Fail. 2014 Jan;16(1):103-11
pubmed: 24453099
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
N Engl J Med. 2002 Oct 31;347(18):1442-4
pubmed: 12409548
ESC Heart Fail. 2021 Aug;8(4):2876-2888
pubmed: 34080791
Curr Heart Fail Rep. 2018 Feb;15(1):17-23
pubmed: 29353333
J Am Coll Cardiol. 2019 Aug 6;74(5):601-612
pubmed: 31370950
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
ESC Heart Fail. 2022 Jun;9(3):1853-1863
pubmed: 35355441
Am J Clin Nutr. 2008 Jan;87(1):106-13
pubmed: 18175743
Eur J Heart Fail. 2019 Nov;21(11):1434-1442
pubmed: 31373161
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
J Am Coll Cardiol. 2014 Dec 2;64(21):2281-93
pubmed: 25456761
Eur J Heart Fail. 2018 Nov;20(11):1570-1577
pubmed: 30225878
Circ Heart Fail. 2011 May;4(3):324-31
pubmed: 21350053
Circ Heart Fail. 2018 Nov;11(11):e005254
pubmed: 30571197
Eur Heart J. 2007 Jun;28(11):1310-8
pubmed: 17185303
Circ J. 2011;75(10):2403-10
pubmed: 21778592
Circ J. 2017 Jun 23;81(7):966-973
pubmed: 28367843
Crit Care Med. 2008 Jan;36(1 Suppl):S129-39
pubmed: 18158472
Circ J. 2009 Oct;73(10):1893-900
pubmed: 19644216
Am J Med. 2016 Jun;129(6):635.e15-26
pubmed: 27215991
Geriatr Gerontol Int. 2017 Dec;17(12):2629-2634
pubmed: 29265757
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Eur Heart J. 2009 Feb;30(4):478-86
pubmed: 19106198
Am J Cardiol. 2016 Jun 15;117(12):1953-8
pubmed: 27156830
N Engl J Med. 2021 Jul 15;385(3):203-216
pubmed: 33999544
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Geriatr Gerontol Int. 2016 Jun;16(6):709-15
pubmed: 26171645
Circ Heart Fail. 2020 Oct;13(10):e006798
pubmed: 32986957